SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001520138-20-000356
Filing Date
2020-08-06
Accepted
2020-08-06 17:21:25
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDING JUNE 30, 2020 bivi-20200630_10k.htm 10-K 739636
2 EXHIBIT 4.4 bivi-20200630_10kex4z4.htm EX-4.4 18058
3 EXHIBIT 31.1 bivi-20200630_10kex31z1.htm EX-31.1 10090
4 EXHIBIT 31.2 bivi-20200630_10kex31z2.htm EX-31.2 9838
5 EXHIBIT 32.1 bivi-20200630_10kex32z1.htm EX-32.1 4560
6 EXHIBIT 32.2 bivi-20200630_10kex32z2.htm EX-32.2 4430
7 GRAPHIC image_001.jpg GRAPHIC 28096
  Complete submission text file 0001520138-20-000356.txt   2781900

Data Files

Seq Description Document Type Size
8 XBRL LABEL FILE bivi-20200630_lab.xml EX-101.LAB 222430
9 XBRL PRESENTATION FILE bivi-20200630_pre.xml EX-101.PRE 163840
10 XBRL SCHEMA FILE bivi-20200630.xsd EX-101.SCH 29095
11 XBRL INSTANCE FILE bivi-20200630.xml EX-101.INS 387642
12 XBRL CALCULATION FILE bivi-20200630_cal.xml EX-101.CAL 36100
13 XBRL DEFINITION FILE bivi-20200630_def.xml EX-101.DEF 76597
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-39015 | Film No.: 201082841
SIC: 2834 Pharmaceutical Preparations